Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA, Valproic Acid, and Theophylline for AML
NCT00175812Phase 2Completed
- Sponsor
- University of Bergen
- Start
- Nov 2004
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tretinoin, valproic acid and theophylline in acute myeloid leukemia (AML), sponsored by University of Bergen. Primary endpoint: Overall Survival. Started Nov 2004; status: completed.
02
Drugs
tretinoinvalproic acidtheophylline
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00175812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175812.